Can we identify cystic fibrosis from skeletal remains? A proposed differential diagnosis

Melanie M Beasley1, Clare K Remy2

  • 1Department of Anthropology, Purdue University, West Lafayette, Indiana, USA.

Insights

Cystic fibrosis (CF) can be identified through skeletal analysis, particularly bone disease and unique chronic sinusitis. Further research is needed to confirm the diagnostic sensitivity of these skeletal markers.

Area of Science:

  • Paleopathology
  • Genetics
  • Medical Anthropology

Background:

  • Cystic fibrosis (CF) is a prevalent genetic disorder, primarily affecting individuals of European ancestry, with significant demographic impact in North America and Europe.
  • Advances in medical care have extended the lifespan of CF patients, leading to the emergence of chronic complications such as bone disease and fractures.
  • CF patients exhibit a distinct form of chronic sinusitis characterized by a medial bulge in the nasal aperture's lateral walls, differentiating it from non-CF sinusitis.

Purpose of the Study:

  • To evaluate the potential of skeletal analysis in identifying individuals with cystic fibrosis.
  • To highlight the unique skeletal manifestations associated with CF, including bone disease and specific sinonasal changes.
  • To assess the current evidence base for using skeletal markers in CF diagnosis.

Main Methods:

  • Review of existing medical literature and case studies.
  • Analysis of skeletal and sinonasal features described in patients with cystic fibrosis.
  • Comparison of CF-related skeletal and sinonasal pathologies with non-CF conditions.

Main Results:

  • Skeletal analysis, including bone disease and characteristic chronic sinusitis, provides sufficient evidence for identifying CF.
  • The sinonasal manifestation in CF patients presents a unique medial bulge on the lateral nasal walls.
  • Existing literature suggests potential for skeletal analysis in CF identification, but quantification of lesion sensitivity is pending.

Conclusions:

  • Skeletal analysis, encompassing bone disease and specific sinonasal morphology, offers a viable method for identifying cystic fibrosis.
  • The distinct skeletal and sinonasal features in CF patients warrant further investigation for diagnostic application.
  • Future research should focus on quantifying the sensitivity and specificity of these skeletal markers for confirming a CF diagnosis.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
574
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
318
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
582